Skip to main content
. 2008 Jun 26;149(10):4928–4937. doi: 10.1210/en.2008-0869

Table 1.

Metabolic parameters of the DBA/2J mice

Glycemic status Treatment Final weight 20-wk blood glucose Final GHb
Nondiabetic None 29.7 ± 3.9 (n = 17) 122.1 ± 18.5 (n = 17) 5.8 ± 0.9 (n = 15)
Diabetic STZ 23.5 ± 1.7 (n = 18) 455.2 ± 163.6 (n = 18) 14.2 ± 1.7 (n = 18)
Nondiabetic Rosi 29.2 ± 3.2 (n = 15) 122.8 ± 16.3 (n = 15) 6.0 ± 0.7 (n = 15)
Diabetic STZ and Rosi 23.7 ± 1.5 (n = 13) 509 ± 153.5 (n = 13) 13.6 ± 2.0 (n = 13)

Final weight was reduced in diabetic mice (P < 0.001); 20-wk blood glucose and final GHb were increased (P < 0.001). 

HHS Vulnerability Disclosure